Review
Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment

https://doi.org/10.1016/j.bbadis.2015.12.010Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Vascular cognitive impairment describes deficits secondary to any type of cerebrovascular disease

  • Arteriolosclerosis and cerebral amyloid angiopathy are the most common types of small vessel disease

  • Novel imaging techniques have identified new small vessel disease markers that are associated with cognitive impairment

  • Combinations of neuroimaging markers may show a better correlation between small vessel disease and cognitive performance

Abstract

Dementia is a global growing concern, affecting over 35 million people with a global economic impact of over $604 billion US. With an ageing population the number of people affected is expected double over the next two decades. Vascular cognitive impairment can be caused by various types of cerebrovascular disease, including cortical and subcortical infarcts, and the more diffuse white matter injury due to cerebral small vessel disease. Although this type of cognitive impairment is usually considered the second most common form of dementia after Alzheimer’s disease, there is increasing recognition of the vascular contribution to neurodegeneration, with both pathologies frequently coexisting. The aim of this review is to highlight the recent advances in the understanding of vascular cognitive impairment, with a focus on small vessel diseases of the brain. We discuss recently identified small vessel imaging markers that have been associated with cognitive impairment, namely cerebral microbleeds, enlarged perivascular spaces, cortical superficial siderosis, and microinfarcts. We will also consider quantitative techniques including diffusion tensor imaging, magnetic resonance perfusion imaging with arterial spin labelling, functional magnetic resonance imaging and positron emission tomography. As well as potentially shedding light on the mechanism by which cerebral small vessel diseases cause dementia, these novel imaging biomarkers are also of increasing relevance given their ability to guide diagnosis and reflect disease progression, which may in the future be useful for therapeutic interventions. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.

Keywords

Cerebral small vessel disease
Magnetic resonance imaging
Dementia
Cerebral amyloid angiopathy
Vascular cognitive impairment

Cited by (0)

This article is part of a Special Issue entitled: Vascular contributions to cognitive impairment and dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.